Polpharma Prospers Again On Dutch Natalizumab

 
• By Aidan Fry
  
Poland_Netherland_Gears
Poland's Polpharma has prevailed against Biogen in a Dutch dispute over a natalizumab patent • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin